Home » BioAlliance Pharma Submits a Phase III Clinical Trial Application for Livatag
BioAlliance Pharma Submits a Phase III Clinical Trial Application for Livatag
BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announced the submission of a Phase III clinical trial application for Livatag in the treatment of primary liver cancer to the French Drug Agency.
Business Wire
Business Wire
Upcoming Events
-
07May
-
14May
-
30May